1999
DOI: 10.2131/jts.24.supplementi_79
|View full text |Cite
|
Sign up to set email alerts
|

Reproductive and Developmental Toxicity Study of Gadobenate Dimeglumine Formulation (E7155) (3) : Study of Embryo-Fetal Toxicity in Rabbits by Intravenous Administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0
4

Year Published

2008
2008
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(28 citation statements)
references
References 5 publications
1
23
0
4
Order By: Relevance
“…31 Gadolinium crosses the placenta, where it is presumably excreted by the fetal kidneys into the amniotic fluid. In the era of gadolinium-induced nephrogenic systemic fibrosis, this raises theoretical concerns of toxicity related to disassociation and persistence of free gadolinium.…”
Section: Risks Of Gadolinium Use In Pregnancymentioning
confidence: 99%
“…31 Gadolinium crosses the placenta, where it is presumably excreted by the fetal kidneys into the amniotic fluid. In the era of gadolinium-induced nephrogenic systemic fibrosis, this raises theoretical concerns of toxicity related to disassociation and persistence of free gadolinium.…”
Section: Risks Of Gadolinium Use In Pregnancymentioning
confidence: 99%
“…Magnetic resonance imaging (MRI) is regarded as the modality of choice for acquisition of cross sectional imaging, as no studies to date have demonstrated adverse effects on the fetus from MRI (Figure 1) [5]. Gadolinium, which has been shown to have teratogenic effects in animal models, is not recommended for use during pregnancy [6]. Iodine based contrast should also be avoided during pregnancy.…”
Section: Diagnosismentioning
confidence: 99%
“…Noncontrast MRI can readily detect most common fetal anomalies, therefore, GBCAs are not widely used in fetal MRI. The toxic effect of gadolinium to the fetus has been adequately tested in animals, but data in humans are still limited [15]. This makes gadolinium a category C medication (the safety in humans has not been proven and the impact of prolonged prenatal use remains unclear).…”
Section: Safety Of Mri Contrast Media During Pregnancymentioning
confidence: 99%